Stockreport

MLTX FRAUD UPDATE: Important MoonLake Immunotherapeutics Securities Fraud Class Action Deadline is Approaching for Investors – Contact BFA Law before December 15

MoonLake Immunotherapeutics - Class A Ordinary Shares  (MLTX) 
PDF NEW YORK, Dec. 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against MoonLake Immunothera [Read more]